Medical News

RSS

Emerging trends that drive the U.S. market for trauma fixation devices

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the nearly $3 billion US market for trauma fixation devices will continue to see rapid growth over the next five years despite the recent economic slowdown. MRG's US Markets for Trauma Devices 2010 report finds that this market will remain highly dynamic over the next five years, with competitors introducing specialized devices in previously underserved segments of the trauma fixation market, fueling market growth.

25 Nov 2009

A two-door clinic segregates patients based on how they pay

A radiology clinic in Manhattan's Upper East Side has two doors, an example of a new, two-tiered medical practice model favored by some doctors, MSNBC reports. One door opens to a crowded waiting room while the other opens into a small private room with four chairs and little or no waiting line.

25 Nov 2009

iThemba Pharmaceuticals and Pyxis Discovery sign a collaborative agreement

iThemba Pharmaceuticals' service division and Pyxis Discovery announced today that they have signed a collaborative agreement to jointly market both companies' services.

25 Nov 2009

KHN column: Don't rationalize busting the budget -- start over

In this Kaiser Health News column, Robert Laszewski writes about concerns that the reform measures being considered on Capitol Health do not slow the growth of health care costs.

25 Nov 2009

Senators push for COBRA benefit extension

CongressDaily: "Democratic senators are aiming to pass legislation to extend subsidies to help the unemployed and underemployed afford healthcare coverage before federal funding expires at the end of this year, Sen. Robert Casey Jr., D-Pa., said today. Casey said he expects the Senate to move to the bill following the healthcare bill, which could be difficult depending on how rancorous the debate becomes" (11/24).

25 Nov 2009

Swiss investor acquires Swissray International

Swissray International, Inc. a leading manufacturer of direct digital Radiography (ddR) systems, announced today that its operations have been acquired by a private Swiss Investor with a long term view towards growing Swissray's medical imaging brand. The acquisition included all assets and intellectual property, as well as contracts and inventory.

25 Nov 2009

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.

25 Nov 2009

Johnson & Johnson Focused Funding grant for research on brain cell damage in PD

‏Dr. Sarit Larisch, Head of the Cell Death Research Laboratory and senior lecturer at the University of Haifa, has been awarded the prestigious Johnson & Johnson Focused Funding grant for her research exploring the cause of brain cell damage in Parkinson's disease.

25 Nov 2009

Given Imaging's PillCam SB wireless capsule endoscopy effective in treating GI patients

Given Imaging Ltd., the global leader in patient-friendly GI diagnostic and monitoring solutions, today announced that three new studies demonstrate that PillCam® SB endoscopy has a clear impact on how physicians manage GI patients, including those patients suspected of having Crohn's disease. The studies were presented at the Gastro 2009 conference taking place in London from November 21 to 25.

25 Nov 2009

Major direct health benefits by reducing carbon dioxide and other greenhouse emissions

Tackling climate change by reducing carbon dioxide and other greenhouse emissions will have major direct health benefits in addition to reducing the risk of climate change, especially in low-income countries, according to a series of six papers appearing today (Wed., Nov. 25) in the British journal The Lancet.

25 Nov 2009

Illumina's Board of Directors authorize a new stock repurchase program

Illumina, Inc. today announced that its Board of Directors has approved a new stock repurchase program, authorizing the company to repurchase in the aggregate up to $100 million of its outstanding common stock. The $75 million share repurchase program originally announced on August 24, 2009, recently has been completed.

From Illumina, Inc. 25 Nov 2009

UGR researchers provide early diagnosis of ARMD and keratitis

Researchers from the UGR have provided an early diagnosis of certain ocular diseases that are very common today, such as age-related macular degeneration and keratitis, by applying an existing optical technique that, nevertheless, had never before been used for this purpose.

25 Nov 2009

Novartis to terminate its research collaboration agreement with Idera Pharmaceuticals

Idera Pharmaceuticals, Inc., today announced that Novartis will terminate its research collaboration agreement with the Company, effective as of February 21, 2010.

25 Nov 2009

AARP calls for Idaho's members of Congress to support real health care reform

As the debate over health care reform is expected to pick up in the Senate after Thanksgiving, notices of health care premium increases are hitting mailboxes across Idaho -- leaving many families wondering how they'll be able to afford the hikes. While high health care costs have left nearly 15% of Idaho without insurance, as benefits run out for the state's 67,300 jobless residents that number will jump in the coming months.

25 Nov 2009

Shareholders approve Derma Sciences' reverse stock split

Derma Sciences, Inc. a specialty medical device/pharmaceutical company focused on advanced wound care, announced today that its shareholders granted Derma Sciences' Board of Directors authority to implement a reverse stock split in the range of between 1-to-5 and 1-to-10.

25 Nov 2009

QLT announces litigation settlement with Massachusetts General Hospital

QLT Inc. ("QLT" or the "Company") today announced the settlement of its litigation with the General Hospital Corporation, doing business as Massachusetts General Hospital ("MGH").

25 Nov 2009

Human Genome Sciences submits BLA for ZALBIN

Human Genome Sciences, Inc. today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ZALBIN™ (albinterferon alfa-2b) for the treatment of chronic hepatitis C. The BLA submission includes the results of two pivotal Phase 3 clinical trials showing that 900-mcg albinterferon alfa-2b dosed every two weeks met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) dosed once each week.

25 Nov 2009

TMCI announces a national rollout of its successful "Plan" to reach the nation's teen moms

Lee Daniels' gritty indie film "Precious” follows a suffering pregnant girl struggling against impossible odds. Producer and director Daniels said on NPR's Fresh Air, "I know the cycle has to stop. And that's the beauty of 'Precious.'"

25 Nov 2009

Healthways and Physicians Health Choice agree to provide SilverSneakers Fitness Program

Healthways, Inc. and Physicians Health Choice today announced an agreement to provide the Healthways SilverSneakers® Fitness Program, the nation’s leading exercise program for older adults, to eligible Physicians Health Choice plan members in Texas, Florida, New Mexico and Arkansas beginning in January 2010.

25 Nov 2009

Investors details for initial television advertising campaign to be provided by Muscle Flex

Muscle Flex Inc. (www.MuscleFlexInc.com) announced today it is providing investors details for the initial television advertising campaign for the Beagle StepFit Pedometer.

25 Nov 2009